Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive ChemoradiotherapyJacqueline V. Aredo, Heather A. Wakelee, Jessica A. Hellyer et al.|Journal of Thoracic Oncology|2021Cited by 131
Small Cell Lung Cancer Therapeutic Responses Through Fractal Measurements: From Radiology to Mitochondrial BiologyIsa Mambetsariev, Ravi Salgia|Journal of Clinical Medicine|2019Cited by 12